Sciascia Thomas
CIK 0001229946
Chief Scientific Officer
Filings
11
Latest Feb 20, 2026
Issuers covered
1
Showing
11 of 11
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 17% | -18.6% | -22.0% | +3.9% | -29.1% |
| 90 days | 6 | 33% | -3.1% | -3.6% | +13.0% | -14.9% |
| 180 days | 6 | 0% | -38.7% | -43.0% | -15.0% | -55.6% |
| 365 days | 6 | 0% | -149.9% | -159.7% | -73.1% | -187.0% |
Issuers
Companies where Sciascia Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | 11 | Feb 20, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|